Influence
December 22, 2020

Expanding telemedicine: Regenstrief CEO co-authors blog on AHRQ’s role in supporting telehealth research

The use of telemedicine has greatly increased during the COVID-19 pandemic. Regenstrief President and Chief Executive Officer Peter Embí, M.D., M.S., and fellow members of the Agency for Healthcare Research and Quality (AHRQ) National Advisory Committee authored a blog on the agency’s role in generating evidence to improve telemedicine.

The article identified the urgent need to fill significant evidence gaps regarding the quality and safety of care delivered via telemedicine. The authors discussed telehealth as the next frontier in care delivery and the necessity of making it part of the AHRQ’s research agenda.

Read the blog here

Dr. Embí joined the AHRQ’s National Advisory Council in 2019 and is serving a three-year term. The council provides advice and recommendations to the AHRQ director and the secretary of U.S. Health and Human Services on priorities for a national health services research agenda.

Additional authors on the blog are Tina Hernandez-Boussard, PhD, MPH of Standford University; Karen Amstutz, M.D., MBA of Indiana University Health; and Edmondo Robinson, M.D., MBA, M.S. of Moffitt Cancer Center.

About Peter Embí, M.D., M.S.

In addition to serving as the president and CEO of Regenstrief Institute, Peter Embí, M.D., M.S., is the Leonard Betley Professor of Medicine and associate dean for informatics and health services research at Indiana University School of Medicine, associate director of informatics with Indiana Clinical and Translational Sciences Institute and vice president for Learning Health Systems with Indiana University Health.

Related News

infographic showing statistics from the press release

Recognizing traumatic brain injury as a chronic condition fosters better care over the survivor’s lifetime

INDIANAPOLIS – A commentary, published in the Journal of Neurotrauma, calls for traumatic brain injury to be recognized as

photo of surgeon with quote from Dr. Clint Cary: "the benefit of providing clinical care and also being in a research environment enables us to learn from what we're doing and to report it in a manner that is meaningful to both patients and physicians."

Study finds traditional open surgery for lymph node removal remains gold standard for testicular cancer

INDIANAPOLIS – Although much rarer than either breast or prostate cancers, testicular cancer is the most common solid tumor

Rachel Patzer (center) and other members of the ASN panel

Regenstrief president participates in media panel with national experts

Regenstrief Institute President and CEO Rachel Patzer, PhD, MPH, joined other national experts on Thursday, October 24 on a panel